These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3928559

  • 1. Complete regression of Lewis lung carcinoma by cyclophosphamide in combination with immunomodulators.
    Abe S, Takahashi K, Yamazaki M, Mizuno D.
    Jpn J Cancer Res; 1985 Jul; 76(7):626-30. PubMed ID: 3928559
    [Abstract] [Full Text] [Related]

  • 2. Combination therapy of murine tumors with lentinan, bacterial lipopolysaccharide and a Streptococcus preparation, OK432.
    Abe S, Takahashi K, Tsubouchi J, Yamazaki M, Mizuno D.
    Gan; 1983 Apr; 74(2):273-8. PubMed ID: 6862148
    [Abstract] [Full Text] [Related]

  • 3. Immunotherapy of Madison 109 lung carcinoma and other murine tumors using lentinan.
    Rose WC, Reed FC, Siminoff P, Bradner WT.
    Cancer Res; 1984 Apr; 44(4):1368-73. PubMed ID: 6704958
    [Abstract] [Full Text] [Related]

  • 4. Combination therapy of murine tumors with lentinan plus lipopolysaccharide plus cyclophosphamide.
    Abe S, Tsubouchi J, Takahashi K, Yamazaki M, Mizuno D.
    Gan; 1982 Dec; 73(6):961-7. PubMed ID: 7160585
    [Abstract] [Full Text] [Related]

  • 5. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI, Fuller JA, Kremlev SG, Kamdar SJ, Evans R.
    J Immunol; 1998 Dec 15; 161(12):6977-84. PubMed ID: 9862733
    [Abstract] [Full Text] [Related]

  • 6. Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors.
    Gatanaga T, Takahashi K, Yamazaki M, Mizuno D, Abe S.
    Jpn J Cancer Res; 1985 Jul 15; 76(7):631-6. PubMed ID: 3928560
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy of murine tumors with a degraded D-manno-D-glucan (DMG) from Microellobosporia grisea, and cyclophosphamide.
    Nakajima H, Hashimoto S, Kita Y, Takashi T, Tsukada W, Kohno M, Ogawa H, Abe S, Mizuno D.
    Jpn J Exp Med; 1983 Dec 15; 53(6):263-9. PubMed ID: 6240552
    [Abstract] [Full Text] [Related]

  • 8. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
    Ujiie T.
    Jpn J Cancer Res; 1987 Jul 15; 78(7):737-47. PubMed ID: 3114200
    [Abstract] [Full Text] [Related]

  • 9. [Antitumor effect of bacterial lipopolysaccharide (LPS) and a combination use of LPS and lentinan on C3H/He mice bearing MH-134 tumor].
    Moriya N, Miwa H, Taketsuka S, Orita K.
    Gan To Kagaku Ryoho; 1983 Jul 15; 10(7):1646-52. PubMed ID: 6870308
    [Abstract] [Full Text] [Related]

  • 10. [Combined use of lentinan with X-ray therapy in an experimental mouse tumor system (Part 2). Combined effect on the MM102 syngeneic tumor].
    Shiio T, Ohishi K, Tsuchiya Y, Niitsu I, Hayashibara H, Yoshihama T, Moriyuki H.
    Gan To Kagaku Ryoho; 1988 Mar 15; 15(3):475-9. PubMed ID: 3348633
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K, Tanaka T, Takeuchi M.
    Cancer Treat Rep; 1985 Mar 15; 69(3):285-91. PubMed ID: 3978657
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN, Miloushev AS.
    Biomedicine; 1980 Apr 15; 33(2):42-4. PubMed ID: 6447522
    [Abstract] [Full Text] [Related]

  • 15. [Experimental study on the effectiveness of BRM in radiation therapy--OK-432 and cyclophosphamide].
    Norimura T, Kunugita N, Dohi S, Mukae S, Tsuchiya T.
    Gan No Rinsho; 1988 Oct 15; 34(13):1811-5. PubMed ID: 3199515
    [Abstract] [Full Text] [Related]

  • 16. Anti-tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system.
    Inagawa H, Nishizawa T, Noguchi K, Minamimura M, Takagi K, Goto S, Soma G, Mizuno D.
    Anticancer Res; 1997 Oct 15; 17(3C):2153-8. PubMed ID: 9216680
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
    Suga T, Shiio T, Maeda YY, Chihara G.
    Cancer Res; 1984 Nov 15; 44(11):5132-7. PubMed ID: 6488173
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.
    Inagawa H, Nishizawa T, Honda T, Nakamoto T, Takagi K, Soma G.
    Anticancer Res; 1998 Nov 15; 18(5D):3957-64. PubMed ID: 9854510
    [Abstract] [Full Text] [Related]

  • 19. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
    Akimoto M, Nishihira T, Mori S.
    Gan To Kagaku Ryoho; 1988 Apr 15; 15(4 Pt 2-1):827-33. PubMed ID: 3260467
    [Abstract] [Full Text] [Related]

  • 20. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
    Kanwar JR, Kanwar RK, Pandey S, Ching LM, Krissansen GW.
    Cancer Res; 2001 Mar 01; 61(5):1948-56. PubMed ID: 11280751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.